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From the whole plant of Euphorbia peplus L., five new diterpenes based on a jatrophane skeleton
(pepluanins A-E, 1-5) were isolated, together with two known analogues (6 and 7), which
served to divulge in detail the structure-activity relationships within this class of P-glycoprotein
inhibitors. The results revealed the importance of substitutions on the medium-sized ring
(carbons 8, 9, 14, and 15). In particular, the activity is collapsed by the presence of a free
hydroxyl at C-8, while it increases with a carbonyl at C-14, an acetoxyl at C-9, and a free
hydroxyl at C-15. The most potent compound of the series, pepluanin A, showed a very high
activity for a jatrophane diterpene, outperforming cyclosporin A by a factor of at least 2 in the
inhibition of Pgp-mediated daunomycin transport.
Introduction
Plants of the genus Euphorbia have a rich ethno-
pharmacology already documented in Greek and Roman
medical literature. Thus, the plants were used to reduce
toothache, to remove warts, as purgatives, and in
asthma and bronchial catarrh.1 Anyway, the plants are
so inimical to human flesh that they border on toxic and
have generally been avoided, if not feared, and used very
rarely and cautiously. Recently, the discovery of jatro-
phane diterpenes as a new class of powerful inhibitors
of P-glycoprotein has open new frontiers for research
studies on this genus.2
P-glycoprotein (Pgp) belongs to a family of plasma
membrane proteins encoded by the MDR (multidrug
resistance) gene.3,4 Pgp functions as a membrane-
localized drug transport mechanism that has the ability
to actively pump out all currently prescribed HIV-
protease inhibitors from the intracellular cytoplasm,
substantially attenuating their cytotoxic effect.5,6 Fur-
thermore, Pgp-mediated resistance is not restricted to
a specific inducer but it is generally extended to chemi-
cally unrelated antitumor drugs (cross-resistance).7-9
In a search for natural revertant agents, we have
recently reported the isolation of nine new jatrophane
diterpenoids from Euphorbia dendroides L. These com-
pounds were based on a structurally homogeneous
skeleton and this gave us the possibility to propose a
first insight into the structure-activity relationships
within this class of P-glycoprotein inhibitors.10 The
results showed the existence of a definite structure-
activity relationship that suggested the involvement of
the southwestern fragment of the molecule (C-2/C-5) in
binding, highlighting the relevance of a free OH group
at C-3.10
We now describe from Euphorbia peplus L. the
structure elucidation of five new jatrophane diterpenes,
together with two known compounds, which were
individually investigated for their Pgp-binding proper-
ties. The results were used to extend the structure-
activity relationships to the other oxygenated carbon
atoms of the medium-sized ring (C-7/C-15). In particu-
lar, one of the isolated metabolites, pepluanin A (1),
showed an especially potent activity detected by now
for a jatrophane diterpene, outperforming cyclosporin
A by a factor of at least 2 in the inhibition of Pgp-
mediated daunomycin transport.
Results and Discussion
The EtOAc extract of E. peplus, collected in the
volcanic area of Vesuvio (Campania, Italy) in March
2002 was subjected to successive MPLC and HPLC
chromatographic separations on a silica gel column
(hexane-EtOAc, gradient) to afford compounds 1-7.
Pepluanin A, isolated in relatively high yield (10.1
mg), gave in the HRFABMS spectrum a molecular ion
at m/z 822.3362, corresponding to the formula
C43H51O15N. These data, together with the NMR pro-
files, were indicative of a diterpenoid polyol bearing
several ester groups. The nature of the ester groups has
been identified by 1H and 13C NMR spectra (Tables 1
and 2) that showed the presence of five acetates, one
benzoate, and one nicotinate.
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Besides these signals, the 1H and 13C NMR spectra
also indicated the presence of four methyls (three
singlets and one doublet), two double bonds (one exo-
cyclic and one trans disubstituted), and eight oxygen-
ated sp3 carbons (six were secondary and two tertiary),
seven of which being esterified. The remaining oxygen-
ated function has been ascribed to an hydroxyl group
by the observation of a singlet at ä 3.62 in the 1H NMR
spectrum that exchanges with D2O.
A 2D HSQC spectrum of 1 allowed correlations of
protons with directly linked carbon atoms. By COSY and
HOHAHA techniques the following sequences could be
extracted: C-3 to C-5, C-7 to C-9, and C-11 to C-14,
including C-20.
Extensive study of the 2,3JC-H correlations, obtained
from the 2D HMBC spectrum, allowed the connection
of all the above-deduced moieties. In particular, HMBC
cross-peaks of H-1R and H-1â with C-2 and C-15;
H3-16 with C-1, C-2, and C-3; H-3 with C-2, C-4, and
C-15; and 15-OH with C-1 and C-4 built ring A. Further
cross-peaks of H-5 with C-4 and C-6; H2-17 with C-5
and C-7; and H-8 with C-7, C-9, and C-10 extended the
structure up to this point. Similarly, correlations of
H3-18 and H3-19 with C-9, C-10, and C-11; H3-20 with
C-12, C-13, and C-14; and H-14 with C-12, C-4, and C-15
closed a 12-membered jatrophane ring. The cross-peaks
of H-3 with the benzoate carbonyl and of H-9 with the
nicotinate carbonyl ensured the position of benzoate and
nicotinate at C-3 and C-9, respectively. As a conse-
quence, the other esterified carbons (C-2, C-5, C-7, C-8,
and C-14) must be all acetylated, thus fully defining the
planar structure of pepluanin A.
The relative configuration of 1 was determined by
analyzing the J pattern and the results of NOE cor-
relations. NOE effects of 15-OH with H-1â, H3-16, and
the ortho benzoyl protons and of H-4 with H-3 defined
the relative configuration of ring A, as depicted in Chart
1. Concerning the macrocyclic ring protons, we observed
Table 1. 1H NMR Data (CDCl3) of Pepluanins A-E (1-5) (500
MHz, CDCl3)a
ä (ppm) and multiplicity
H 1 2 3 4 5
1R 2.82 d 2.87 d 2.61 d 3.00 dd 2.98 d
1â 2.15 d 2.06 d 2.23 d 1.60 dd 2.11 d
2 2.21 m
3 5.98 brd 5.94 brd 5.80 brdb 5.43 brs 5.95 brd
4 3.63 brsb 3.76 brs 3.27 brs 2.64 brs 3.60 brs
5 5.83 brs 5.80 brs 5.79 brsb 5.80 brs 5.30 brs
7 5.58 s 5.35 s 5.59 s 4.76 brddb 5.43 s
8 5.38 s 4.15 d 5.25 s 2.05 m 3.90 d
9 5.14 s 5.08 s 4.96 s 4.77 brddb 5.02 s
11 6.10 d 6.14 d 5.92 d 5.84 d 6.14 d
12 5.75 dd 5.66 dd 5.66 dd 5.55 dd 5.55 dd
13 2.83 dqb 2.88 dqb 2.68 dq 3.48 dq 4.01 dq
14 5.23 s 5.14 s 5.10 s
16 1.46 s 1.46 s 1.54 s 0.89 d 1.56 s
17 4.45 brs 4.47 brs 4.45 brs 5.05 brs 4.87 brs
4.82 brs 4.80 brs 4.91 brs 5.09 brs 5.04 brs
18 1.02 s 1.08 s 0.93 s 1.00 s 1.09 s
19 1.26 s 1.36 s 1.38 s 1.04 s 1.29 s
20 1.19 d 1.12 d 1.15 d 1.15 d 1.33 d
4-OH
5- OH
8-OH 2.99 d 3.15 d
15-OH 3.62 s 3.65 3.59 s 4.18 s
OAc 1.97 s 2.02 s 1.93 s 1.99 s 1.80 s
2.03 s 2.11 s 1.99 s 2.00 s 2.21 s
2.03 s 2.21 s 2.03 s 2.15 s
2.11 s 2.10 s 2.15 s
2.25 s 2.17 s 2.17 s
OiBu 2 2.62 mb 1.90 m
OiBu 3 1.18 d 0.50 d
OiBu 4 1.22 d 0.94 d
OMeBu 2 1.98 tq
OMeBu 3 1.52 ddq
OMeBu 3′ 1.29 ddq
OMeBu 4 0.60 t
OMeBu 5 0.91 d
OBz 2,6 8.06 d 8.05 d 8.09 d 8.19 d
OBz 3,5 7.43 tb 7.43 tb 7.45 t 7.43 t
OBz 4 7.57 t 7.58 t 7.57 d 7.56 t
ONic 2 9.30 brs 9.30 brs 9.26 brs
ONic 4 8.35 d 8.38 d 8.34 d
ONic 5 7.42 brddb 7.42 brddb 7.44 brddb
ONic 6 8.82 brd 8.71 brd 8.84 brd
a JH-H. For 1-3, 5: 1R∠1â ) 14.0; 3-4 ) 4-5 ) 7-8 ) 8-9
)17a-17b )1.2 Hz; 11-12 ) 16.0 Hz; 12-13 ) 9.5 Hz; 13-20 )
7.0 Hz. For 2, 4: 8-OH ) 11.5 Hz. 4: 1R∠1â )14.0 Hz; 1R∠2 )
7.7 Hz; 1â∠2 ) 11.0 Hz; 2-16 ) 6.5 Hz; 2-3 ) 7.0 Hz. iBu: 2-3
) 2-4 ) 7.0 Hz. MeBu: 2-3a ) 2-3b ) 3a-4 ) 3b-4 ) 2-5 )
7.0 Hz; 3a-3b ) 14.0 Hz. Bz: 2-3 ) 3-4 ) 7.4 Hz. Nic: 4-5 )
8.0 Hz; 5-6 ) 5.0 Hz. b Overlapped by other signals.
Table 2. 13C NMR Data (CDCl3) of Pepluanins A-E (1-5)
(125 MHz, CDCl3)
ä (ppm) and multiplicity
C 1 2 3 4 5
1 49.91 t 49.68 t 50.77 t 46.15 t 51.03 t
2 88.42 s 88.53 s 88.22 s 38.23 d 88.86 s
3 80.47 d 80.55 d 80.01 d 76.52 d 77.64 d
4 44.76 d 44.78 d 44.58 d 52.70 d 47.83 d
5 71.63 d 71.87 d 71.50 d 68.46 d 68.04 d
6 143.07 s 144.03 s 144.14 s 145.96 s 143.45 s
7 68.04 d 68.01 d 66.79 d 69.02 d 68.54 d
8 70.63 d 70.33 d 70.93 d 34.19 t 69.72 d
9 79.42 d 86.75 d 80.43 d 74.67 d 86.90 d
10 41.00 s 40.44 s 40.68 s 40.38 s 40.67 s
11 133.87 d 133.82 d 134.27 d 138.30 d 136.83 d
12 131.87 d 131.48 d 130.98 d 129.73 d 130.06 d
13 37.34 d 37.54 d 37.37 d 43.23 d 43.79 d
14 81.79 d 79.38 d 79.34 d 211.81 s 211.70 s
15 84.17 s 84.43 s 83.73 s 92.76 s 87.79 s
16 23.76 q 23.58 q 21.98 q 13.33 q 20.88 q
17 109.69 t 109.00 t 110.03 t 110.14 t 112.09 t
18 26.72 q 27.48 q 26.55 q 26.27 q 26.77 q
19 22.92 q 23.05 q 23.25 q 23.05 q 22.90 q
20 23.55 q 23.53 q 23.48 q 19.28 q 19.53 q
OAc 170.81 s 171.15 s 170.45 s 170.41 s 170.27 s
170.80 s 170.25 s 170.44 s 169.94 s 169.30 s
169.75 s 168.59 s 169.65 s 169.84 s
169.74 s 169.64 s 169.75 s
168.00 s 168.06 s 169.47 s
22.47 q 22.48 q 22.29 q 21.23 q 22.23 q
20.87 q 21.16 q 20.82 q 21.17 q 20.72 q
20.62 q 20.51 q 20.64 q 20.88 q
20.48 q 20.55 q 20.82 q
20.28 q 20.44 q 20.70 q
OiBu 175.01 s 174.55 s
33.82 d 33.34 d
19.30 q 18.86 q






OBz 163.87 s 164.75 s 164.68 s 164.80 s
129.72 s 130.03 s 130.08 s 129.97 s
129.67 d 129.62 d 129.64 d 129.96 d
128.33 d 128.39 d 128.37 d 128.27 d
133.13 d 133.09 d 133.10 d 133.03 d
ONic 164.50 s 165.67 s 165.45 s
151.27 d 151.55 d 150.68 d
125.98 s 125.05 s 125.71 s
137.27 d 137.62 d 137.99 d
123.29 d 123.33 d 123.72 d
153.80 d 153.98 d 153.54 d
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a rather peculiar coupling pattern of compound 1, with
all coupling constants on the order of 0-2 Hz, thus
suggesting an orthogonal relationship between the
protons of the macrolide. This feature has already been
found for all ¢6(17),¢11-jatrophanes isolated so far from
other Euphorbia species.11 Among the NOE effects,
those of the methyls with the macrocyclic protons (H3-
19/H-8, H3-18/H-11, H3-18/H-7, H3-20/H2-17) and among
the protons (H-13/H-4, H-13/H-11, H-13/H-1R, H-11/
H-7, H-5/H-8) were diagnostic, allowing us to completely
define the relative stereochemistry pattern of the jat-
rophane core of 1 (Chart 1). Moreover, it should be noted
that the small value JH-4/H-5 (1.2 Hz) has been cor-
related with a predominant conformer of the 12-
membered ring with the exo-methylene group pointing
outward and H-5 pointing inward.12 Accordingly, H-5
showed ROESY cross-peak with both OH-15 and with
H-12.
Pepluanins B-E (2-5) are closely related to peplua-
nin A. In particular, apart from C-14, they differ from
one another by their acylation pattern. Consequently,
stereostructure elucidation of these molecules was
greatly aided by comparison of their spectroscopic data
with those obtained for pepluanin A and for the other
known jatrophanes. Anyway, it should be noted that a
complete set of 2D NMR spectra (COSY, HSQC, HMBC)
was acquired for each metabolite in order to gain the
complete and unambiguous assignment of 1H and 13C
NMR resonances as listed in Tables 1 and 2, respec-
tively. The same relative stereochemistry previously
assigned to pepluanin A was also confirmed for peplu-
anins B-E by 2D NMR ROESY spectroscopy.
Pepluanin B (2, 2.5 mg) gave in the HRFABMS
spectrum a molecular ion peak at m/z 822.3725, corre-
sponding to the formula C44H55O14N. The NMR spectra
of 2 (Tables 1 and 2) revealed close similarities with
those of 1 and showed the lack of an ester group, thus
pointing to a hexasubstituted jatrophane skeleton for
this compound. The nature of the ester groups has been
determined by 1H and 13C NMR spectra as three
acetates, one 2-methyl butanoate, one benzoate, and one
nicotinate. The 1H NMR spectra showed the presence
of an additional hydroxyl group, resonating as an
exchangeable doublet at ä 2.99, mutually coupled with
a signal at ä 4.15 (d, J ) 11.5 Hz). HMBC correlations
allowed us to assign the last signal to H-8, thus locating
the free hydroxyl group at C-8. HMBC correlations also
placed the 2-methyl butanoate at C-7 and confirmed the
same position of all the other ester groups as that of
pepluanin A, as already suggested from the similarities
of the NMR resonances for pepluanins A and B.
Pepluanin C (3, 7.1 mg), C41H54O15 by HRFABMS,
was isolated as a colorless amorphous solid. Analysis
of its 1H and 13C NMR spectra (Tables 1 and 2) indicated
the same core lipid structure of pepluanins A and B and
in addition revealed the presence of five acetyls, an
isobuthyryl, and a benzoyl group. An exchangeable
singlet at ä 3.59 was attributed to 15-OH by the same
evidences as those obtained for 1 and 2. HMBC cross-
peaks of H-5 (ä 5.79 brs) with the carbonyl of the
isobutyrate (ä 175.01) and of H-7 (ä 5.59 s) with the
carbonyl of the benzoate (ä 164.68) indicated the linkage
of isobuthyryl and benzoyl at C-5 and C-7, respectively.
As a consequence, the other esterified carbons (C-2, C-8,
C-9, and C-14) must be acetylated.
Pepluanin D (4, 6.3 mg), C30H42O11 by HRFABMS,
showed some remarkable differences when compared to
pepluanins A-C: (i) in the 1H NMR of 4 (Table 1), the
signal due to H3-16 appeared as a doublet shifted upfield
(ä 0.89, d, in 4 vs ä 1.46, s, in 1), coupled with a proton
signal at ä 2.21 (H-2); (ii) the absence in the 1H NMR
of 4 of the characteristic singlet due to H-14 (see Table
1) and the presence in the 13C NMR spectrum (Table 2)
of a ketone carbonyl at ä 211.81, coupled in the HMBC
spectrum with H-13, H-11, H-1R, and H-1â; (iii) a
dramatic change in the 1H NMR resonances of H-7/H-8
and H-9 in compound 4. A combined analysis of the 2D
COSY, HSQC, and HMBC spectra allowed us to identify
at position 8 a methylene carbon (ä 2.05, m), to define
the core structure of pepluanin D as depicted in Chart
1, and to locate the five acetyls at C-3, C-5, C-7, C-9,
and C-15. The 1H and 13C NMR assignments of 4 are
reported in Tables 1 and 2.
Pepluanin E (5, 5.1 mg) had the formula C41H49O13N
by HRFABMS. A preliminary analysis of the MS and
NMR data indicated a jatrophane core structure esteri-
fied with two acetyls, one benzoyl, one isobuthyryl, and
one nicotinyl and bearing two hydroxyls (one on a
methine carbon and the other on a quaternary carbon).
A carbonyl function at ä 211.70 appeared in the 13C
NMR spectrum, thus indicating, as found for compound
4, a ketone functionality at C-14. However, the substi-
tution pattern of pepluanin E appeared more related
to that of pepluanin B. A detailed analysis (2D COSY,
HSQC, and HMBC) of 5 in comparison to 2 confirmed
the same substitutions for both compounds, the differ-
ences being confined to the ester group at C-7 (iBu in 5
instead of MeBu in 2) and to the group on C-14 (a ketone
for 5 instead of an acetate for 2). Thus, the structure of
5 has been assigned as indicated in Chart 1.
The EtOAc extract of E. peplus also afforded the
known compounds 6 and 7, which were characterized
by comparing their NMR data with those reported in
the literature.11
The biological activity of the isolated jatrophane
diterpenes (1-7) was assayed through their ability to
inhibit P-glycoprotein-mediated drug efflux from cancer
cells leading to intracellular accumulation. The obtained
percentages of inhibition for this series of compounds
at 5 íM is reported in Table 3, related to cyclosporin A,
the “golden standard” of Pgp modulators, taken here as
reference (100%). The 5 íM jatrophane concentration
Chart 1
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was chosen because previously for analogues a maximal
inhibition in the 5-10 íM range has been shown10 with
a half-maximal effect around 1-2 íM.
Our previous studies on a first series of jatrophane
diterpenes, euphodendroidins A-I,10 isolated from E.
dendroides, evidenced the involvement of ring A in Pgp
binding. In particular, the critical role of the hydroxyl
group at position 3, together with the negative effect of
this group at C-2 have been observed. In addition,
substitution at the proximal C-5 with a large group also
decreased the activity. We have now gone beyond these
data and underlined the importance of the substitution
on other carbons of the medium-sized ring in modulating
the activity.
Pepluanin A (1) was found here to be an even more
powerful inhibitor, with an efficiency at least 2-fold
higher (207 ( 17%, Table 3) than the conventional
modulator cyclosporin A (Figure 1). This appears quite
interesting also in the light of some structure-activity
considerations that can be drawn. First of all, compari-
son of the activity of 1 and 2, the only stuctural
differences of which being confined to C-8 substitution,
evidenced a collapse of the inhibitory potency (207 (
17% in 1 vs 60 ( 4% in 2). This clearly indicates that
also the substitution pattern at the carbons of the
medium-sized ring is of great importance for the activ-
ity. Another point to clarify is that pepluanin A, unlike
the majority of the other tested jatrophanes, euphoden-
droidins A-I10 and compounds 4, 5, 7 (Chart 1), has an
acetoxyl function at C-14 instead of a carbonyl. It is
rather difficult at this point to draw a definitive conclu-
sion on this structural detail. Anyway, by comparing the
activity of 5 (94 ( 5%) with that of 2 (60 ( 4%),
essentially differing for this structural detail, we could
hypothesize that the observed inhibitory potency of 1
might be further increased by a carbonyl at position 14.
Similarly, a positive effect might be expected by sub-
stituting nicotinyl by acetoxyl at C-9, since 6 (80 ( 6%)
is more efficient than 2 (60 ( 4%). An additional key
point is the presence of a free hydroxyl group at C-15,
as found in the most powerful compounds tested. In fact,
compounds 4 (76 ( 7%) and 7 (47 ( 7%), presenting an
ester function at this position, exhibited the lowest
efficiency.
In conclusion, the present series of seven jatrophane
diterpenes has allowed us to extend their structure-
activity relationships, highlighting the importance of an
acetoxyl at C-8, by comparison to a free hydroxyl, and
of a free hydroxyl at C-15. Moreover, a carbonyl at C-14
and acetoxyl at C-9 are also favorable substitutions.
Within the set of diterpenes tested by now, pepluanin
A appears a powerful Pgp inhibitor, very promising to
improve drug therapy in multidrug-resistant cancer.
Further studies on structure-activity relationships,
regarding the 3-D structure modeling on the jatro-
phanes and the interaction with the receptorial site of
Pgp, are in progress.
Experimental Section
General Experimental Procedures. Low- and high-
resolution FAB mass spectra (glycerol matrix) were measured
on a Prospec Fisons mass spectrometer. Optical rotations were
determined on a Perkin-Elmer 192 polarimeter equipped with
a sodium lamp (589 nm) and 10-cm microcell. 1H and 13C NMR
spectra were recorded at 500 and 125 MHz, respectively, on a
Bruker AMX-500 spectrometer. Chemical shifts were referred
to the residual solvent signal (CDCl3: ä‚ 7.26, äC 77.0). The
multiplicities of 13C NMR resonances were determined by
DEPT experiments. 1H connectivities were determined by
using COSY experiments; one-bond heteronuclear 1H-13C
connectivities were determined with 2D HSQC pulse sequence
with an interpulse delay set for 1JCH of 130 Hz. Two- and three-
bond heteronuclear 1H-13C connectivities were determined
with 2D NMR HMBC experiments, optimized for 2-3JCH of 8
Hz. Measurement of spatial coupling was obtained through
2D ROESY experiments. Medium-pressure liquid chromatog-
raphy (MPLC) was performed on a Bu¨chi 861 apparatus using
silica gel (230-400 mesh) as the stationary phase. HPLC in
isocratic mode was performed on a Varian apparatus equipped
with a RI-3 refractive index detector using Merck columns
[semipreparative LiChrocart Si60 column (10í) with a flow
rate of 2.5 mL/min and analytical LiChrospher Si60 (5 ím)
with a flow rate of 1 mL/min].
Plant Material. Samples of Euphorbia peplus L. were
collected in waste places in Parco Gussone, Portici (NA) in
March 2002. The plant material was identified by R.M., and
a voucher specimen is kept at the Dipartimento di Arboricol-
tura, Botanica e Patologia Vegetale.
Extraction and Isolation. Fresh, whole plants (2.097 kg,
fresh plant), including latex and roots, were extracted five
times with 7 L of EtOAc at room temperature. The obtained
EtOAc extract (81.9 g) was partitioned between H2O and
EtOAc, to remove hydrophilic and gummy compounds, and
then the sole apolar fraction (35.5 g) was chromatographed
Table 3. Inhibition by Pepluanins A-E (1-5), Relatively to
CsA, of Cellular P-glycoprotein-mediated Daunomycin Efflux
Monitored by Its Intracellular Accumulationa
substitution
compd C-8 C-9 C-14 C-15
% inhibn of daunomycin
efflux with respect to CsA
1 OAc ONic OAc OH 207 ( 17
2 OH ONic OAc OH 60 ( 4
3 OAc OAc OAc OH 54 ( 5
4 H OAc O OAc 76 ( 7
5 OH ONic O OH 94 ( 5
6 OH OAc OAc OH 80 ( 6
7 H ONic O OAc 47 ( 7
a The increase in daunomycin accumulation produced by each
compound was determined under the same conditions as in Figure
1, the effect produced by CsA being taken as 100% ((9.7%).
Figure 1. Accumulation of daunomycin in P-glycoprotein
overexpressing human K562/R7 leukemic cells, as monitored
by flow cytometry. The cells were exposed to daunomycin for
1 h in the absence or presence of either cyclosporin A (CsA) or
pepluanin A (1) and quickly washed; intracellular drug
concentrations were compared by the shift in fluorescence (FL
channel). The results are the mean ( SD of at least three
independent experiments.
Pepluanins A-E Journal of Medicinal Chemistry, 2004, Vol. 47, No. 4 991
using a gradient system from hexane 100% to EtOAc 100%.
We have further purified fractions eluted in hexane:EtOAc 1:1,
hexane:EtOAc 3:7, and hexane:EtOAc 2:8.
The first fraction (hexane:EtOAc 1:1) was successively
purified on an HPLC direct phase column, using hexane:EtOAc
65:35 as the mobile phase, and afforded two new compounds,
pepluanin C (7.1 mg) and pepluanin D (6.3 mg).
The second fraction (hexane:EtOAc 3:7) was further purified
first on semipreparative columns and then on analytic HPLC
columns (both eluted with hexane:EtOAc 6:4), affording the
known compound 6 (8.2 mg) and the new compound pepluanin
E (5.1 mg).
From the third fraction (hexane:EtOAc 2:8) analyzed first
on semipreparative HPLC column, using hexane:EtOAc 4:6
as the mobile phase, and then with analytic HPLC column,
with hexane:EtOAc 6:4 as eluent, we isolated known compound
7 (7.7 mg), and the two new compounds, pepluanin A (10.1
mg) and pepluanin B (2.5 mg).
Pepluanin A: yield 10.1 mg, colorless amorphous solid;
[R]25D +34.4° (c ) 0.1, CHCl3); HRFABMS (positive ion) found
m/z 822.3362 [M + H]+, calculated for C43H51O15N m/z
821.32804; 1H NMR (CDCl3) data, Table 1; 13C NMR (CDCl3)
data, Table 2.
Pepluanin B: yield 2.5 mg, colorless amorphous solid;
[R]25D +25.7° (c ) 0.1, CHCl3; HRFABMS (positive ion) found
m/z 822.3725 [M + H]+, calculated for C44H55O14N m/z
821.36434; 1H NMR (CDCl3) data, Table 1; 13C NMR (CDCl3)
data, Table 2.
Pepluanin C: yield 7.1 mg, colorless amorphous solid;
[R]25D +3.0° (c ) 0.1, CHCl3); HRFABMS (positive ion) found
m/z 787.3521 [M + H]+, calculated for C41H54O15 m/z 786.3447;
1H NMR (CDCl3) data, Table 1; 13C NMR (CDCl3) data, Table
2.
Pepluanin D: yield 6.3 mg, colorless amorphous solid;
[R]25D -39.4° (c ) 0.1, CHCl3; HRFABMS (positive ion) found
m/z 579.2789 [M + H]+, calculated for C30H42O11 m/z 578.2715;
1H NMR (CDCl3) data, Table 1; 13C NMR (CDCl3) data, Table
2.
Pepluanin E: yield 5.1 mg, colorless amorphous solid;
[R]25D +28.8° (c ) 0.1, CHCl3); HRFABMS (positive ion) found
m/z 764.3309 [M + H]+, calculated for C41H49O13N m/z 763.3226;
1H NMR (CDCl3) data, Table 1; 13C NMR (CDCl3) data, Table
2.
Purity Criteria for Target C ompounds. The degree of
purity of all tested compounds (1-7) was over 95% as indicated
by the appearance of a single peak using two different HPLC
eluent systems. Retention times (tR) are expressed in minutes.
Pepluanin A: hexane/EtOAc 4:6 with tR 33.0; CH2Cl2/EtOAc
45:55 with tR 20.5.
Pepluanin B: hexane/EtOAc 6:4 with tR 37.6; CH2Cl2/EtOAc
65:35 with tR 25.1.
Pepluanin C: hexane/EtOAc 6:4 with tR 54.2; CH2Cl2/EtOAc
65:35 with tR 42.3.
Pepluanin D: hexane/EtOAc 6:4 with tR 60.0; CH2Cl2/EtOAc
65:35 with tR 48.1.
Pepluanin E: hexane/EtOAc 6:4 with tR 25.5; CH2Cl2/EtOAc
65:35 with tR 13.3.
Compound 6: hexane/EtOAc 62:38 with tR 36.3; CH2Cl2/
EtOAc 7:3 with tR 27.1.
Compound 7: hexane/EtOAc 6:4 with tR 47.1; CH2Cl2/EtOAc
65:35 with tR 35.3.
Biological Assay. P-Glycoprotein-overexpressing K562/R7
human leukemic cells were incubated with 10 íM daunomycin,
as described previously,13,14 in the presence or absence of
inhibitor. The cells were then washed and analyzed by flow
cytometry on a FACS-II apparatus. Assays were performed
in duplicate, in a least three separate experiments. Cyclosporin
A, a potent inhibitor of P-glycoprotein, was used as a positive
control, at a final 2 íM concentration. The ability of 5 íM
pepluanin to inhibit P-glycoprotein-mediated drug efflux was
quantified by comparing the induced shift in fluorescence to
that obtained with cyclosporin A.
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